Meta Pixel

News and Announcements

OncoSil Medical CEO Presentation & AGM October 2016

  • Published October 18, 2016 3:29PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

18th October 2016, ASX Announcement

Achievements Delivered FY16

September 2015 – Submission of CE Mark application for OncoSil™

October 2015 – OncoSil™ CE Mark application granted Fast Track review status

December 2015 – Investigational Device Exemption submitted to the FDA for OncoPac-1 clinical study

January 2016 – Chris Roberts appointed Independent Non-Executive Director

February 2016 – $10 million private placement to Regal Funds Management

March – April 2016 – Q-Submissions meeting with FDA
-Responses to CE Mark and FDA questions

May 2016 – OncoSil Medical completes hiring of senior management for the Leadership Team

June 2016 – IDE Amendment submitted to the FDA for OncoPac-1 clinical study

To view the full Presentation, please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now